Castle Rock Banner
File #: 19-2081   
Type: Consent Status: Agenda Ready
File created: 5/23/2019 In control: City Council
On agenda: 6/20/2019 Final action:
Title: Authorize negotiation and execution of a contract with BioFire Defense, LLC, for a syndromic infectious disease molecular diagnostics instrument and accessories, in an amount not to exceed $76,500. (Note: Sole source contracts are exempt from the City Code Chapter 2-9D Minority Owned and Women Owned Business Enterprise Procurement Program; therefore, no subcontracting goals were established).
Attachments: 1. Recommendation for Action
Date Action ByActionAction DetailsMeeting Details
No records to display.
Posting Language
Title
Authorize negotiation and execution of a contract with BioFire Defense, LLC, for a syndromic infectious disease molecular diagnostics instrument and accessories, in an amount not to exceed $76,500.

(Note: Sole source contracts are exempt from the City Code Chapter 2-9D Minority Owned and Women Owned Business Enterprise Procurement Program; therefore, no subcontracting goals were established).

Body
Lead Department
Purchasing Office.

Client Department(s)
Austin Fire Department.

Fiscal Note
Funding in the amount of $76,000 is available in the Austin Fire Department's Homeland Security and Emergency Management Grants 3575001 and 3280601. Funding in the amount of $500 is available in the Fiscal Year 2018-2019 Operating Budget of the Austin Fire Department.

Purchasing Language:
Sole Source.


For More Information:
Inquiries should be directed to the City Manager's Agenda Office, at 512-974-2991 or AgendaOffice@austintexas.gov or to Leyla Mammadova, at 512-974-2938 or Leyla.Mammadova@austintexas.gov.


Additional Backup Information:
The contract is for a FilmArray 2.0 instrument, a pathogen detection system, and accessories for the Austin Fire Department (AFD). This pathogen detection system includes software and system specific reagents which allows AFD to run biologic sample analysis and to determine a necessary emergency response in circumstances where unspecified contaminants have been disseminated.

AFD requires this critical equipment to detect pathogen-specific nucleic acids collected from samples where the safety of the community is concerned during situations in which life-threatening contaminants have been detected. The tests include respiratory panels, blood culture identification panels, gastrointestinal panels, and meningitis-encephalitis panels. This system is a Food and Drug Administration cleared system that integrates sample preparation, amplification, detection and analysis. The easy to use system requires little train...

Click here for full text